From Bench to Bedside

More universities are focusing efforts on technology transfer and industry partnerships to bring new therapies to market Technology transfer, or the commercialization of scientific discoveries, is becoming more common in the field of hematology, with...

Online Exclusives

FDA Clears Investigational New Drug Application for VOR33 in CD33-Positive AML

The U.S. Food and Drug Administration (FDA) has cleared Vor Biopharma’s Investigational New Drug (IND) application for its hematopoietic stem cell therapy VOR33. This...

Once Coronavirus Eases, Will Other Viruses Surge?

According to the Centers for Disease Control and Prevention (CDC) and other virus trackers, aside from the coronavirus, respiratory and gastrointestinal viruses are circulating...

News

From the Blood Journals

Large Meta-Analysis Confirms Predictive Value of MRD Negativity in Myeloma

Achievement of measurable residual disease (MRD) negativity is associated with significant improvements in progression-free survival (PFS) and overall survival (OS) in patients with multiple...

Azacitidine Maintenance Fails to Improve Post-Transplant Outcomes in High-Risk AML and...

Maintenance treatment with single-agent azacitidine at a dose of 32 mg/m2 daily for five days did not lead to improved survival in patients with...

Multimedia

Deepu Madduri: Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma

Deepu Madduri, MD, discusses data from the phase Ib/II CARTITUDE-1 study evaluating chimeric antigen receptor (CAR) T cell therapy ciltacabtagene autoleucel in patients with...

Steven Pipe: Etranacogene Dezaparvovec Gene Therapy for Hemophilia B

Steven Pipe, MD, shares safety and efficacy data from a phase III study of etranacogene dezaparvovec gene therapy in patients with hemophilia B.

Charlotte Bradbury: Adding Mycophenolate to Corticosteroid for ITP

Mycophenolate alongside corticosteroids may be considered as an effective first-line treatment option for some patients with immune thrombocytopenia. Charlotte Bradbury, MD, discusses results from...

José Blanco: Accessory Splenectomy in Patients with Immune Cytopenias

José Blanco, MD, discusses whether searching for an accessory spleen or performing accessory splenectomy is a safe and effective treatment for patients with refractory...

On Location

BOSTON: Selinexor Improves Progression-Free Survival in Relapsed/Refractory Myeloma

The combination of once-weekly selinexor with bortezomib and dexamethasone (SVd) demonstrated a 30% reduction in...
On location

CRISPR Gene Editing May Offer Curative Potential for Sickle Cell Disease

CRISPR-based gene editing techniques may offer curative potential for sickle cell disease (SCD) when used...
On location

Loss of STK11/LKB1 Drives Progression to Leukemia in Myeloproliferative Neoplasms

Results from a CRISPR/Cas9 screening study suggest that loss of STK11 promotes progression to leukemia...
On location

FLAG-IDA Plus Venetoclax Associated With High Response Rates in Acute Myeloid Leukemia

Adding venetoclax to fludarabine, cytarabine, granulocyte-colony stimulating factor, and idarubucin (FLAG-IDA) translated into high response...
On location

Examining Immune Response in Patients with Hematologic Malignancy After COVID-19 Infection

Patients with a history of a hematologic malignancy who survive COVID-19 infection have similar immune...
On location

Phase III Trial Supports Efficacy of Subcutaneous Daratumumab in Relapsed/Refractory Myeloma

Patients with relapsed/refractory multiple myeloma (MM) who were treated with a combination of subcutaneous daratumumab...

Latest Headlines

Advertisement

ASH Directions

ASH Directions

ASH Names New Editor-in-Chief of ASH Clinical News, Announces Donation of NGS Equipment to...

ASH Names New Editor-in-Chief of ASH Clinical News ASH Clinical News is excited to announce the selection of its next editor-in-chief, Aaron T. Gerds, MD, who...
ASH Directions

Highlights of ASH® Goes Virtual, Trainee Awards for Underrepresented Minorities, and more

Highlights of ASH® Goes Virtual Each year, the American Society of Hematology’s (ASH’s) Highlights of ASH® meeting series offers a synopsis of the top hematology...

Sign up for our
eNewsletter!

The Society Pages

Remembering Mark Smith, Cancer Researchers Receive 2020 AAAS Fellow Distinction, and more

Remembering Mark Smith (1962 - 2020) Mark P. Smith, MBChB, died suddenly on September 24, 2020, at the age of 58.Since 1995, Dr. Smith has...
The Society Pages

NIH Award Supports Sickle Cell Disease Treatment in Malawi, NCI Outstanding Investigator Awards Granted...

Saad Usmani Receives 2020 Multiple Myeloma Excellence Award from International Congress on Controversies in MM The International Congress on Controversies in Multiple Myeloma (COMy) has...
The Society Pages

Kwaku Ohene-Frempong Wins Assistant Secretary of Health Exceptional Service Medal, ASH Members Elected to...

Kwaku Ohene-Frempong Wins Assistant Secretary of Health Exceptional Service Medal  U.S. Assistant Secretary for Health Adm. Brett P. Giroir, MD, recently presented American Society of Hematology...

From Bench to Bedside

More universities are focusing efforts on technology transfer and industry partnerships to bring new therapies to market Technology transfer, or the commercialization of scientific discoveries,...

Leaving the Bedside

Career opportunities for doctors extend far beyond the patient care setting. When choosing to become a physician, most people expect to spend their entire working...

What Makes a Good Leader?

Health care leadership roles are often awarded to top clinicians and researchers, but experts say successful leaders need a different set of skills.  As cases...